Microbial community dynamics and mechanistic insights into rapid ammonia nitrogen removal via Acinetobacter harbinensis HITLi7 enhanced activated carbon.

J Environ Manage

Tianjin Key Laboratory of Clean Energy and Pollution Control, School of Energy and Environmental Engineering, Hebei University of Technology, Tianjin, 300401, China. Electronic address:

Published: February 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The biological enhanced activated carbon (BEAC) system, utilizing the bioaugmentation with Acinetobacter harbinensis HITLi7, demonstrated remarkable performance in removing ammonia nitrogen (NH-N) from aquatic environments. However, the mechanism through which HITLi7 bioaugmentation influenced microbial communities remains incompletely understood. Therefore, a comparative analysis of startup speed and NH-N removal efficiency was conducted between biological activated carbon (BAC) and BEAC bench-scale systems, with an in-depth examination of microbial dynamics and mechanisms within BEAC. Within 16 days post bioaugmentation, the biomass of BEAC (BEAC_1 and BEAC_2) was 4.75/9.07 times that of BAC, with NH-N removal efficiencies 29.36%/28.68% higher. 16-135 days, there was no significant difference in biomass among the groups. Specifically, from day 17-90, the NH-N removal efficiency of BEAC was still 25.80%/25.37% higher than that of BAC. After 90 days, the effluent NH-N levels from BEAC were more stable. In BEAC, the abundance of HITLi7 decreased while the abundance of Nitrosomonas increased, exhibiting a characteristic of "species compensation". Subsequently, Candidatus_Nitrotoga and Nitrospira became enriched. After 16 days, the total abundance of Nitrosomonas, Candidatus_Nitrotoga, and Nitrospira in BEAC was 3.21%-5.66% and 3.68%-10.07% higher than that in BAC. The microbial community in BEAC was more influenced by diffusion limitation, especially for Nitrosomonas and Nitrospira. Within the microbial co-occurrence network, while Nitrosomonas and Nitrospira lacked a direct correlation with HITLi7, the presence of intermediates might potentially hinder the diffusion of Nitrosomonas and Nitrospira. This study deepened our understanding of how HITLi7 bioaugmentation affects microbial community structure, dynamics, and co-occurrence patterns.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jenvman.2025.124350DOI Listing

Publication Analysis

Top Keywords

microbial community
12
activated carbon
12
nh-n removal
12
nitrosomonas nitrospira
12
beac
9
ammonia nitrogen
8
acinetobacter harbinensis
8
harbinensis hitli7
8
enhanced activated
8
hitli7 bioaugmentation
8

Similar Publications

EVOLVING TRENDS AND EMERGING THEMES IN GUT MICROBIOTA RESEARCH: A COMPREHENSIVE BIBLIOMETRIC ANALYSIS (2015-2024).

Arq Gastroenterol

September 2025

The Japanese Society of Internal Medicine, Editorial Department, Tokyo, Japan.

Background: This study aims to analyze research trends and emerging insights into gut microbiota studies from 2015 to 2024 through bibliometric analysis techniques. By examining bibliographic data from the Web of Science (WoS) Core Collection, it seeks to identify key research topics, evolving themes, and significant shifts in gut microbiota research. The study employs co-occurrence analysis, principal component analysis (PCA), and burst detection analysis to uncover latent patterns and the development trajectory of this rapidly expanding field.

View Article and Find Full Text PDF

Genomic characterization of normal and aberrant human milk production.

Sci Adv

September 2025

Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, USA.

Breastfeeding is essential for reducing infant morbidity and mortality, yet exclusive breastfeeding rates remain low, often because of insufficient milk production. The molecular causes of low milk production are not well understood. Fresh milk samples from 30 lactating individuals, classified by milk production levels across postpartum stages, were analyzed using genomic and microbiome techniques.

View Article and Find Full Text PDF

Subcutaneous vedolizumab dose intensification in inflammatory bowel disease patients: the OPTI-VEDO multicenter study from the GETAID.

J Crohns Colitis

September 2025

Department of Gastroenterology, University Hospital of Marseille Nord, Assistance Publique-Hôpitaux de Marseille (AP-HM), Aix-Marseille University, Marseille, France.

Background And Aims: While this strategy is frequently used for other biologics, real-world evidence on subcutaneous (SC) vedolizumab (VDZ) dose intensification in inflammatory bowel disease (IBD) is lacking. This study aimed to assess the effectiveness and safety of SC VDZ intensification.

Methods: We conducted a retrospective study in 25 centers including all patients with active ulcerative colitis (UC) or Crohn's disease (CD) (defined by PRO2), and incomplete or loss of response to SC VDZ 108mg EOW when the drug was intensified.

View Article and Find Full Text PDF

Background: The brain-gut-microbiome (BGM) axis is a communication network through which the brain and gastrointestinal microbiota interact via neural, hormonal, immune, and gene expression mechanisms. Gut microbiota dysbiosis is thought to contribute to neurocognitive disorders, including perioperative neurocognitive disorder (PND), and to various metabolic abnormalities. Recently, we reported that sevoflurane induces neurocognitive deficits in exposed rats as well as their future offspring, with male offspring being particularly affected (intergenerational PND).

View Article and Find Full Text PDF